Two Onc Docs cover image

ASH 2025 LBA BRUIN-CLL 313 Update: Pirtobrutinib vs Bendamustine/Rituximab in 1L CLL

Two Onc Docs

00:00

Peripheral smear and prognostic markers

Sam and Kareen discuss smudge cells, IGHV stability, and favorable versus adverse cytogenetic features.

Play episode from 02:10
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app